Strados Labs Case Study
Research Collaboration with Scripps Translational Research
What’s Inside?
This case study highlights the DETECT-AHEAD sub-study, part of the nationwide DETECT Health Study led by Scripps Research, which tested whether adding sensor data could improve early detection of infectious diseases such as influenza, RSV, and COVID-19. While wearables like Garmin and Fitbit devices collected useful data on activity and physiology, they could not capture cough — one of the most burdensome and common symptoms. To address this gap, participants were equipped with the RESP® Biosensor for continuous cough monitoring alongside self-reported symptom surveys.
Among 16 participants who provided baseline recordings, only six reported cough, yet the RESP Biosensor captured cough in 11 patients. Across all participants, 2,252 coughs were detected, including more than 1,000 from patients who reported no coughing. In total, 75% of self-reported symptom data did not match validated results from objective monitoring.
The study also demonstrated strong patient adherence and device usability. All participants successfully followed device instructions, and several voluntarily continued using the RESP Biosensor for extended periods of up to 15 days. These findings reinforce the value of objective cough monitoring to complement self-reporting, enhance decentralized study design, and improve infectious disease surveillance.
